Compounds > n-acetylsphingosine

n-acetylsphingosine and Breast Neoplasms

n-acetylsphingosine has been researched along with Breast Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blumenthal, R; Francella, N; Garg, H; Kang, JH; Marquez, VE; Sigano, DM1
Ahn, EH; Chang, CC; Hsieh, CY; Schroeder, JJ; Sun, W; Yang, H1
Deng, Z; Du, WW; Fang, L; Jeyapalan, Z; Seth, A; Shan, SW; Yang, BB; Yang, BL; Yee, AJ; Zhang, Y1
Goodhew, KL; Holly, JM; Keith, AJ; Perks, CM; Savage, PB; Winters, ZE1
Benedict, M; Dixit, VM; Jäättelä, M; Shayman, JA; Tewari, M1
Gill, ZP; Holly, JM; Newcomb, PV; Perks, CM2
Gill, ZP; Holly, JM; Maile, LA; Perks, CM1
Deng, J; Hung, MC; Kloosterboer, F; Klostergaard, J; Levitt, ML; Liao, Y; Zhang, H1
Clarke, JB; Clemmons, DR; Holly, JM; McCaig, C; Perks, CM1

Other Studies

10 other study(ies) available for n-acetylsphingosine and Breast Neoplasms

ArticleYear
Ceramides: branched alkyl chains in the sphingolipid siblings of diacylglycerol improve biological potency.
    Bioorganic & medicinal chemistry, 2009, Feb-15, Volume: 17, Issue:4

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Ceramides; Humans; Molecular Structure; Signal Transduction; Sphingolipids; Structure-Activity Relationship; T-Lymphocytes

2009
Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.
    International journal of oncology, 2019, Volume: 54, Issue:2

    Topics: Breast; Breast Neoplasms; Carcinogenesis; Cell Differentiation; Cell Transformation, Neoplastic; Epithelial Cells; Female; Humans; MCF-7 Cells; Neoplastic Stem Cells; Sphingosine; Stem Cells

2019
Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Green Fluorescent Proteins; Humans; Mice; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sphingosine; Taxoids; Tyrphostins; Versicans

2011
Prolactin acts as a potent survival factor for human breast cancer cell lines.
    British journal of cancer, 2004, Jul-19, Volume: 91, Issue:2

    Topics: Apoptosis; Breast Neoplasms; Cell Survival; Combined Modality Therapy; Enzyme Inhibitors; Female; Humans; Prolactin; Sphingosine; Tumor Cells, Cultured

2004
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.
    Oncogene, 1995, Jun-15, Volume: 10, Issue:12

    Topics: Antigens, Surface; Apoptosis; Base Sequence; bcl-X Protein; Breast Neoplasms; Cell Division; Ceramides; Dexamethasone; Drug Resistance; Enzyme Activation; fas Receptor; Female; Humans; Luciferases; Molecular Sequence Data; NF-kappa B; Phospholipases A; Phospholipases A2; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Quinacrine; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingosine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1995
Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner.
    The Journal of biological chemistry, 1997, Oct-10, Volume: 272, Issue:41

    Topics: Apoptosis; Breast Neoplasms; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Signal Transduction; Sphingosine; Tumor Cells, Cultured

1997
Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines.
    British journal of cancer, 1999, Volume: 79, Issue:5-6

    Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin A; Cyclin B; Cyclin B1; Female; Humans; Insulin-Like Growth Factor I; Kinetics; Oligopeptides; Recombinant Proteins; S Phase; Signal Transduction; Sphingosine; Tumor Cells, Cultured

1999
The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells.
    Endocrinology, 1999, Volume: 140, Issue:9

    Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Cell Membrane; DNA Fragmentation; Drug Synergism; Epithelial Cells; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Peptide Hydrolases; Recombinant Proteins; Serine Proteinase Inhibitors; Somatomedins; Sphingosine; Sulfones; Tumor Cells, Cultured

1999
Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis.
    Oncogene, 2002, Jan-03, Volume: 21, Issue:1

    Topics: Adenovirus E1A Proteins; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Breast Neoplasms; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Ceramides; Enzyme Inhibitors; Female; Humans; Melanoma, Experimental; Mice; Protein Structure, Tertiary; Radiation Tolerance; Recombinant Fusion Proteins; Second Messenger Systems; Sphingosine; Transfection; Tumor Cells, Cultured; Ultraviolet Rays

2002
Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells.
    Biochemical and biophysical research communications, 2002, Jun-28, Volume: 294, Issue:5

    Topics: Apoptosis; Breast Neoplasms; Cell Division; Cell Line; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Mutation; Somatomedins; Sphingosine; Tumor Cells, Cultured

2002